Cost effectiveness of one to one STI prevention interventions

Sexually Transmitted Infections

Volumn 83, Issue 6, 2007, Pages 423-424

  Chesson, Harrell W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; PATIENT COUNSELING; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION; SCREENING; SEXUALLY TRANSMITTED DISEASE;

BENCHMARKING; COST-BENEFIT ANALYSIS; COUNSELING; HUMANS; SEXUALLY TRANSMITTED DISEASES; UNITED STATES; UNITED STATES PUBLIC HEALTH SERVICE;

EID: 35748962589     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2007.026641     Document Type: Editorial

References (10)

1. Barham I, Lewis D, Latimer N. One to one interventions to reduce sexually transmitted Sex Transm Infect 2007;83:441-7.
2. Rietmeijer CA. Risk reduction counselling for prevention of sexually transmitted infections: how it works and how to make it work. Sex Transm Infect 2007;83:2-9.
3. Ward H. One-to-one counselling for STI prevention: not so much whether as how. Sex Transm Infect 2007;83:1.
4. Joseph KS. Form should follow function in epidemiologic modeling: Author's response. J Clin Epidemiol 2005;85:965-6.
5. Roberts TE, Robinson S, Barton P, et al. Screening for Chlamydia trachomatis: a systematic review or the economic evaluations and modelling. Sex Transm Infect 2000;82:193-200.
6. Chesson HW, Pinkerton SD. Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions. J Acquir Immune Defic Syndr 2000;24:48-56.
7. Hutchinson AB, Farnham PG, Dean HD, et al. The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. J Acquir Immune Defic Syndr 2006;43:451-7.
8. Chesson HW, Blandford JM, Gift TL, et al. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health 2004;36:11-19.
9. Blandford JM, Gift TL. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women. Sex Transm Dis 2006;33:S117-21.
10. Hu D, Hook EW, III, Goldie SJ. Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Ann Intern Med 2004;141:501-13.